FDA Adverse Event Death Summary report: N

WALLFLEX BILIARY

MDR report key: 25283689 · Received May 26, 2026

Report

Report Number
3005099803-2026-02083
Event Type
Death
Date Received
May 26, 2026
Date of Event
January 1, 2010
Report Date
May 26, 2026
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
PNB
PMA / PMN Number
K240464
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BLOCK B3: EXACT DATE UNKNOWN, EVENT OCCURRED BETWEEN JANUARY 1, 2010 AND JANUARY 1, 2023. BLOCK D4, H4: THE COMPLAINANT WAS UNABLE TO PROVIDE THE COMPLAINT DEVICE UPN AND LOT NUMBER. BECAUSE THE PRODUCT IS UNKNOWN AT THIS TIME, WE ARE UNABLE TO PROVIDE THE COMPLETE UNIQUE IDENTIFIER (UDI) # AND OTHER PRODUCT SPECIFIC INFORMATION. IF ADDITIONAL DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. BLOCK E1: INITIAL REPORTER CITY: (B)(6). BLOCK G2: LITERATURE SOURCE: THOMAS GUILMOTEAU, ET AL. DIRECT COMPARISON OF SIMULTANEOUS AND SEQUENTIAL ENDOSCOPIC METALLIC BILATERAL STENTING IN MALIGNANT HILAR BILIARY OBSTRUCTION. WORLD J GASTROENTEROL 2025 MAY 21; 31(19): 101913. DOI: 10.3748/WJG. V31.I19.101913. BLOCK H6: IMDRF PATIENT CODE E1109 CAPTURES THE REPORTABLE EVENT OF CHOLANGITIS. IMDRF PATIENT CODE E1109 CAPTURES THE REPORTABLE EVENT OF SEPSIS. IMDRF IMPACT CODE F02 CAPTURES THE REPORTABLE EVENT OF DEATH.

Description of Event or Problem · 0

BOSTON SCIENTIFIC BECAME AWARE OF EVENTS INVOLVING A WALLFLEX BILIARY STENTS THROUGH THE ARTICLE "DIRECT COMPARISON OF SIMULTANEOUS AND SEQUENTIAL ENDOSCOPIC METALLIC BILATERAL STENTING IN MALIGNANT HILAR BILIARY OBSTRUCTION" BY THOMAS GUILMOTEAU, ET AL. THIS RETROSPECTIVE STUDY FOCUSED ON THE DIFFERENT DRAINAGE TECHNIQUES USING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY FOR MALIGNANT HILAR BILIARY OBSTRUCTION. ALL PATIENTS WHO UNDERWENT BILATERAL BILIARY METALLIC STENTING DURING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) FOR MHBO IN CLERMONT-FERRAND UNIVERSITY HOSPITAL BETWEEN JANUARY 1, 2010 AND JANUARY 1, 2023. CONVENTIONAL SEQUENTIAL SBS PLACEMENT WAS PERFORMED AT OUR INSTITUTION BETWEEN 2010 AND 2017. SINCE 2017, SIMULTANEOUS SBS PLACEMENT HAS BEEN PERFORMED ON PATIENTS WITH UNRESECTABLE MHBOS REQUIRING BILATERAL DRAINAGE. THE PATIENT COHORT WAS DIVIDED INTO THOSE WHO UNDERWENT SEQUENTIAL SBS OR SIS PLACEMENT BETWEEN 2010 AND 2017 (SEQUENTIAL GROUP) AND THOSE WHO UNDERWENT SIMULTANEOUS SBS PLACEMENT BETWEEN 2017 AND 2023 (SIMULTANEOUS GROUP). THE TWO GROUPS WERE COMPARED RETROSPECTIVELY. THE ARTICLE REPORTED PROCEDURAL DETAILS AND OUTCOMES FOLLOWING THE SEQUENTIAL SBS TECHNIQUE. ADVERSE EVENTS INCLUDED CHOLANGITIS WITH MULTIVISCERAL FAILURE PROGRESSING TO SEPTIC SHOCK, WHICH RESULTED IN DEATH. PLEASE REFER TO THE REFERENCED ARTICLE FOR FULL DETAILS, DATA ANALYSIS, AND LIST OF PARTICIPATING INVESTIGATORS AND INSTITUTIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
73833 WALLFLEX BILIARY BILIARY STENT SYSTEM FOR BENIGN STRICTURES PNB BOSTON SCIENTIFIC CORPORATION

Patients

Seq Age Sex Outcome Treatment
1